The accumulation of five quinolone antibacterial agents by Escherichia coli

The Journal of Antimicrobial Chemotherapy
J M DiverR Wise

Abstract

The accumulation of five radiolabelled quinolone antibacterial agents by Escherichia coli KL16 was examined using a vacuum filtration method. Preliminary experiments were performed to determine the optimum quinolone concentration, inoculum of cells, filter washing regimen and filter type. All five quinolones showed a similar biphasic pattern of accumulation with high radioactive counts cell-associated during the first ten seconds of the assay, followed by steadily increasing accumulation over 30 min. Analysis of the mean accumulation after 30 min for each quinolone showed that there was no direct relationship between quinolone accumulation and antibacterial activity (as quantified by the MIC or bactericidal activity). Mechanistic investigations showed that accumulation was decreased by low reaction temperatures, acid pH and the presence of the metabolic inhibitors 2,4-dinitrophenol, potassium cyanide and sodium azide. These results suggest that quinolone accumulation by E. coli KL16 is partly dependent on cell metabolism and may proceed by an active transport mechanism. Treatment of cells with EDTA was found not to increase quinolone accumulation, suggesting that the outer membrane of E. coli KL16 does not act as a permeability...Continue Reading

Citations

Jul 29, 2000·Biochemical and Biophysical Research Communications·J ChevalierM Malléa
Apr 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L E Bryan, J Bedard
Apr 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C S LewinJ T Smith
Feb 1, 1994·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·W V KernE Andriof
Jan 1, 1993·International Journal of Antimicrobial Agents·A Bryskier
Jan 1, 1993·International Journal of Antimicrobial Agents·W CullmannA Braunsteiner
Jun 25, 1999·The Journal of Antimicrobial Chemotherapy·L J PiddockA E Asuquo
Jun 1, 1990·Antimicrobial Agents and Chemotherapy·L J PiddockR Wise
Aug 1, 1992·Antimicrobial Agents and Chemotherapy·C McCaffreyN H Georgopapadakou
Feb 1, 1994·Antimicrobial Agents and Chemotherapy·L J Piddock
Aug 22, 2000·Antimicrobial Agents and Chemotherapy·V Ricci, L J Piddock
Feb 19, 2002·Antimicrobial Agents and Chemotherapy·S RaherisonC M Bébéar
Apr 1, 1995·Journal of Chemotherapy·M H TeixeiraF Teixeira
Jul 7, 2016·MBio·Jessica M A Blair, Laura J V Piddock
Jun 6, 2019·Annals of the New York Academy of Sciences·Helen I Zgurskaya, Valentin V Rybenkov
Nov 18, 2020·Nature Chemical Biology·Shibin ZhaoDerek S Tan
Mar 17, 2021·Chemical Reviews·Jigneshkumar Dahyabhai PrajapatiMathias Winterhalter
Apr 30, 2021·Molecular Pharmaceutics·Mohammad Sharifian Gh
Aug 1, 1996·Antimicrobial Agents and Chemotherapy·I MorrisseyL L Shen
Jul 3, 2018·ACS Infectious Diseases·Ramkumar IyerAlice L Erwin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.